Abstract

50 We have previously reported significant background gene effects on the phenotype of mice with targeted deletion of the AT 1A receptor gene ( Agtr1a ). On 129 or C57BL/6 backgrounds, most Agtr1a-/- mice die before weaning and those that survive develop marked abnormalities of kidney structure, including atrophy of the renal papilla and medial thickening of small renal arteries. In contrast, peri-natal survival and kidney structure are normal in F 1 (C57BL/6 x 129) Agtr1a-/- animals, suggesting that there are distinct recessive genetic modifiers on both the C57BL/6 and 129 backgrounds that modulate the phenotype of AT 1A receptor-deficiency. To further explore the characteristics of these modifying loci, we performed inter-crosses between F 1 (C57BL/6 x 129) Agtr1a- /- mice and evaluated the phenotypes of the resulting F2 Agtr1a-/- progeny. A simple model of two recessive modifier loci, one from each strain with complete penetrance, predicts that 44% of these F2 animals should manifest the trait of interest (either mortality or vascular pathology). Among 70 consecutive F2 progeny, only 4 pups were lost between birth and 21 days of age (94% survival). On pathological examination of the surviving mice, 33 or 50% had typical renal vascular pathology, while the remaining 33 had normal renal vessels. The frequency of post-natal mortality was significantly less than that predicted by this 2 locus model (p<0.0003 by chi-square), suggesting that there are multiple modifying loci for this trait. On the other hand, for renal vascular pathology, the observed number of affected F2 animals (50%) was not significantly different from the number predicted by our hypothetical model (p=0.31 by chi-square). These findings support a model of two distinct recessive modifier loci, one from each strain, that confer susceptibility to vascular pathology. Efforts are underway to indentify these genetic modifiers by genomic micro-satellite analysis.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.